Search





Search





Markets
/
Stocks
/
ecor
/

electroCore, Inc.

ECOR

Add to Watchlist

6.085USD

-0.205-3.26%

Close 07-31 16:00（ET）Quotes delayed by 15 min

48.71MMarket Cap

LossP/E TTM

electroCore, Inc.

6.085

-0.205-3.26%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-3.26%

5 Days

-1.70%

1 Month

-29.57%

6 Months

-8.63%

Year to Date

+35.67%

1 Year

-12.07%

Key Figures

6.240Open

6.330High

37.06KVolume

LossP/E TTM

LossP/E Dynamic

--Dividend TTM

0.46%Turnover Ratio

6.290Prev. Close

5.980Low

145.10KTurnover

LossP/E Static

-28.50P/B

0.00%Div Yield TTM

-97.59%ROA

9.68052wk High

0.89Volume Ratio

-11.89MNet Profit

8.00MShares

-1.7700EPS TTM

0.79Beta

-478.70%ROE

4.16052wk Low

5.56%Amplitude

87.27%Gross Margin

48.71MMarket Cap

-4.58Reward/Risk

5.25%Risk Rate

TradingKey Stock Score of electroCore, Inc.

Currency: USD Updated: 2026-07-31

Key Insights

electroCore, Inc.'s fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 72 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 19.57.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

electroCore, Inc.'s Score

Industry at a Glance

Industry Ranking

72 / 199

Overall Ranking

152 / 4281

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

electroCore, Inc. Highlights

StrengthsRisks

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 99.83% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 32.03M.

Fairly Valued

The company’s latest PE is -3.44, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 923.46K shares, decreasing 26.43% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 0.00 shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.24.

Analyst Rating

Based on 5 analysts

Buy

Current Rating

19.570

Target Price

+222.41%

Upside Space

electroCore, Inc. News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 5 analysts

Buy

Current Rating

19.570

Target Price

+222.41%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

109

Total

Median

Average

Company name

Ratings

Analysts

electroCore, Inc.

ECOR

Dexcom Inc

DXCM

Stryker Corp

SYK

Medtronic PLC

MDT

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

...

Indicators

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.091

Neutral

RSI(14)

39.489

Neutral

STOCH(KDJ)(9,3,3)

30.840

Neutral

ATR(14)

0.547

Low Volatility

CCI(14)

-20.299

Neutral

Williams %R

64.453

Sell

TRIX(12,20)

-1.198

Sell

StochRSI(14)

42.546

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

6.117

Sell

MA10

6.194

Sell

MA20

6.413

Sell

MA50

7.797

Sell

MA100

7.091

Sell

MA200

6.372

Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

electroCore, Inc. Info

Ticker SymbolECOR

CompanyelectroCore, Inc.

CEOGoldberger (Daniel S)

Websitehttps://www.electrocore.com/

Shareholders

Shareholders

Proportion

Zhang (Tianyi)

8.86%

Hilve Holdings Ltd

6.24%

Theofilos (Charles Steve)

5.36%

Errico (Thomas J.)

4.20%

Goldberger (Daniel S)

2.61%

Other

72.74%

Popular Instruments

FAQs

What is the current price of electroCore, Inc. (ECOR)?



The current price of electroCore, Inc. (ECOR) is 6.08.

What is the symbol of electroCore, Inc.?



The ticker symbol of electroCore, Inc. is ECOR.

What is the 52-week high of electroCore, Inc.?



The 52-week high of electroCore, Inc. is 9.68.

What is the 52-week low of electroCore, Inc.?



The 52-week low of electroCore, Inc. is 4.16.

What is the market capitalization of electroCore, Inc.?



The market capitalization of electroCore, Inc. is 49.44M.

Is electroCore, Inc. (ECOR) currently rated as Buy, Hold, or Sell?



According to analysts, electroCore, Inc. (ECOR) has an overall rating of Buy, with a price target of 19.57.

What is the Earnings Per Share (EPS TTM) of electroCore, Inc. (ECOR)?



The Earnings Per Share (EPS TTM) of electroCore, Inc. (ECOR) is -1.65.